Santiago Isbert Perlender is Co-Founder and Chief Technology Officer (CTO) of Innova Trials, an international clinical research organization headquartered in Miami. His career combines business leadership, software development, artificial intelligence and the technological transformation of clinical research. His interest in intelligent systems and artificial neural networks began in 1994, when he was just 21 years old, marking the start of an engagement with the field spanning more than three decades.
En 1995 se publicó Artificial Intelligence: A Modern Approach, la influyente obra de Stuart Russell y Peter Norvig que contribuiría a definir los fundamentos de la inteligencia artificial moderna. Actualmente mantiene un diálogo fluido con el profesor Russell y es miembro de la International Association for Safe and Ethical AI (IASEAI), organización internacional presidida por el reconocido académico de la Universidad de California, Berkeley. Esta vinculación refleja su compromiso con una inteligencia artificial responsable, segura y centrada en el ser humano.
As a developer and creator of original technology solutions, he has advanced AI platforms addressing concrete challenges in clinical research. These include ALPHI, designed for intelligent protocol interpretation and assistance to research professionals; InnovaScoring, focused on strategic clinical study assessment; and systems for automating clinical queries, processing documents, analyzing information and coordinating intelligent agents. His work combines software architectures, language models, neural networks, automation and technology governance, with particular attention to operational efficiency, security and traceability.
Es autor de tres libros dedicados a la inteligencia artificial y sus implicaciones para la humanidad: IA: El último invento humano, El alma de la inteligencia y El guardián del umbral. Su actividad intelectual se complementa con exposiciones y participación en encuentros internacionales en São Paulo, Los Ángeles y Miami, donde promueve una visión de la tecnología comprometida con la ética, el desarrollo científico y la innovación.
A strong advocate for Latin America's scientific and technological capabilities, he believes the region must move beyond consuming technology and become a leading force in creating and developing it. His vision supports building locally developed solutions for clinical research that can compete internationally and strengthen the region's technological independence.
His beginnings were rooted in applying knowledge in service of financial activity, an experience that shaped his rigorous view of systems, risk and decision-making. Today, he holds strategic and financial leadership responsibilities at CINME in Argentina, where he leads initiatives in AI governance, development and implementation. He approaches each challenge as an engineer: with structure, precision and the ability to build. Yet every project also carries an artistic dimension, because passion can turn work into a lasting piece of creation. As CTO of Innova Trials, his goal is to transform clinical research through technologies that empower professionals, streamline processes and bring innovation closer to those who ultimately give it meaning: patients.
More than three decades exploring artificial intelligence. Today, developing technology to transform clinical research.